Deacetyldiltiazem (BioDeep_00000405541)

   


代谢物信息卡片


Deacetyldiltiazem

化学式: C20H24N2O3S (372.1507554)
中文名称: 地尔硫卓杂质F
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CN(C)CCN1C2=CC=CC=C2SC(C(C1=O)O)C3=CC=C(C=C3)OC
InChI: InChI=1S/C20H24N2O3S/c1-21(2)12-13-22-16-6-4-5-7-17(16)26-19(18(23)20(22)24)14-8-10-15(25-3)11-9-14/h4-11,18-19,23H,12-13H2,1-3H3/t18-,19+/m1/s1

描述信息

同义名列表

1 个代谢物同义名

Deacetyldiltiazem



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Dong-Hyun Choi, Jin-Seok Choi, Cheng Li, Jun-Shik Choi. Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin. Pharmacological reports : PR. 2011; 63(6):1574-82. doi: 10.1016/s1734-1140(11)70724-1. [PMID: 22358108]
  • Soon-Pyo Hong, Joon-Seung Yang, Jung-Yeon Han, Sung-Il Ha, Joong-Wha Chung, Young-Youp Koh, Kyong-Sig Chang, Dong-Hyun Choi. Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin. The Journal of pharmacy and pharmacology. 2011 Jan; 63(1):129-35. doi: 10.1111/j.2042-7158.2010.01160.x. [PMID: 21189658]
  • Nicolas Bertrand, Céline Bouvet, Pierre Moreau, Jean-Christophe Leroux. Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication. ACS nano. 2010 Dec; 4(12):7552-8. doi: 10.1021/nn101924a. [PMID: 21067150]
  • Young-Ah Cho, Dong-Hyun Choi, Jun-Shik Choi. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats. The Journal of pharmacy and pharmacology. 2009 Jun; 61(6):825-9. doi: 10.1211/jpp.61.06.0017. [PMID: 19505375]
  • C Li, J S Choi. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Die Pharmazie. 2008 Nov; 63(11):815-8. doi: NULL. [PMID: 19069242]
  • Soon-Pyo Hong, Dong-Hyun Choi, Jun-Shik Choi. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats. Cardiovascular therapeutics. 2008; 26(4):269-75. doi: 10.1111/j.1755-5922.2008.00060.x. [PMID: 19035878]
  • Soon-Pyo Hong, Kyoung-Sig Chang, Dong-Hyun Choi, Jun-Shik Choi. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats. Archives of pharmacal research. 2007 Jan; 30(1):90-5. doi: 10.1007/bf02977783. [PMID: 17328247]
  • Jun-Shik Choi, Hyo-Kyung Han. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats. International journal of pharmaceutics. 2005 Nov; 305(1-2):122-8. doi: 10.1016/j.ijpharm.2005.09.004. [PMID: 16226412]
  • Hyun Jin Choi, Jun-Shik Choi. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats. Archives of pharmacal research. 2005 Aug; 28(8):970-6. doi: 10.1007/bf02973885. [PMID: 16178425]
  • Jun Shik Choi, Jin Pil Burm. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits. Archives of pharmacal research. 2004 Feb; 27(2):254-8. doi: 10.1007/bf02980114. [PMID: 15022730]
  • Suryanarayana Sista, John Chi-Keung Lai, Okponanabofa Eradiri, Kenneth S Albert. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration. Journal of clinical pharmacology. 2003 Oct; 43(10):1149-57. doi: 10.1177/0091270003257214. [PMID: 14517197]
  • Espen Molden, Per Wiik Johansen, Grethe Helen Bøe, Stein Bergan, Hege Christensen, Hans Erik Rugstad, Helge Rootwelt, Leon Reubsaet, Gustav Lehne. Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype. Clinical pharmacology and therapeutics. 2002 Sep; 72(3):333-42. doi: 10.1067/mcp.2002.127396. [PMID: 12235455]
  • Jun S Choi, Yoon G Kim. Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan. Biopharmaceutics & drug disposition. 2002 Apr; 23(3):115-20. doi: 10.1002/bdd.298. [PMID: 12173546]
  • J S Choi, J H Lee, J P Burm. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits. Archives of pharmacal research. 2001 Aug; 24(4):333-7. doi: 10.1007/bf02975102. [PMID: 11534767]
  • M A Bregante, J J Aramayona, L J Fraile, M A Garcia, C Solans. Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels. Xenobiotica; the fate of foreign compounds in biological systems. 2000 Aug; 30(8):831-41. doi: 10.1080/00498250050119871. [PMID: 11037114]
  • P K Yeung, J D Feng, S J Buckley. Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparison of diltiazem with its major metabolites. The Journal of pharmacy and pharmacology. 1998 Nov; 50(11):1247-53. doi: 10.1111/j.2042-7158.1998.tb03341.x. [PMID: 9877310]
  • K M Williamson, G D Dunham. Plasma concentrations of diltiazem and desacetyldiltiazem in an overdose situation. The Annals of pharmacotherapy. 1996 Jun; 30(6):608-11. doi: 10.1177/106002809603000608. [PMID: 8792947]
  • C Coors, H G Schulz, F Stache. Development and validation of a bioanalytical method for the quantification of diltiazem and desacetyldiltiazem in plasma by capillary zone electrophoresis. Journal of chromatography. A. 1995 Nov; 717(1-2):235-43. doi: 10.1016/0021-9673(95)00622-4. [PMID: 8520677]
  • D Paczkowski, R Dabrowski, D Sitkiewicz, Z Sadowski. Analysis of diltiazem and desacetyldiltiazem in serum by high-performance liquid chromatography. Polish journal of pharmacology. 1995 Sep; 47(5):429-34. doi: NULL. [PMID: 8868135]
  • W Homsy, M Lefebvre, G Caillé, P du Souich. Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies. Pharmaceutical research. 1995 Apr; 12(4):609-14. doi: 10.1023/a:1016226601988. [PMID: 7597000]
  • D R Rutledge, A H Abadi, L M Lopez. Liquid chromatographic determination of celiprolol, diltiazem, desmethyldiltiazem and deacetyldiltiazem in plasma using a short alkyl chain silanol deactivated column. Journal of pharmaceutical and biomedical analysis. 1994 Jan; 12(1):135-40. doi: 10.1016/0731-7085(94)80022-7. [PMID: 8161601]
  • V Hutt, F Janik, J Kappler, G Pabst, V Ravelli, M Maccari, H Jaeger. Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers. Arzneimittel-Forschung. 1993 Jul; 43(7):737-43. doi: NULL. [PMID: 8369005]
  • W H Frishman. A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension. Journal of clinical pharmacology. 1993 Jul; 33(7):612-22. doi: 10.1002/j.1552-4604.1993.tb04713.x. [PMID: 8366186]
  • D R Rutledge, A H Abadi, L M Lopez, C A Beaudreau. High-performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain silanol deactivated column. Journal of chromatography. 1993 May; 615(1):111-6. doi: 10.1016/0378-4347(93)80296-g. [PMID: 8340449]
  • B A Finegan, M D Hussain, Y K Tam. Pharmacokinetics of diltiazem in patients undergoing coronary artery bypass grafting. Therapeutic drug monitoring. 1992 Dec; 14(6):485-92. doi: 10.1097/00007691-199212000-00009. [PMID: 1485371]
  • Y H Lee, M H Lee, C K Shim. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure. Pharmaceutical research. 1992 Dec; 9(12):1599-606. doi: 10.1023/a:1015868525978. [PMID: 1488404]
  • C Maskasame, S Lankford, S A Bai. The effects of chronic oral diltiazem and cimetidine dosing on the pharmacokinetics and negative dromotropic action of intravenous and oral diltiazem in the dog. Biopharmaceutics & drug disposition. 1992 Oct; 13(7):521-37. doi: 10.1002/bdd.2510130706. [PMID: 1489943]
  • D C Dimmitt, D K Yu, A T Elvin, D H Giesing, R C Lanman. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination. Biopharmaceutics & drug disposition. 1991 Oct; 12(7):515-23. doi: 10.1002/bdd.2510120705. [PMID: 1932613]
  • P Hubert, P Chiap, J Crommen. Automatic determination of diltiazem and desacetyldiltiazem in human plasma using liquid-solid extraction on disposable cartridges coupled to HPLC--Part I: Optimization of the HPLC system and method validation. Journal of pharmaceutical and biomedical analysis. 1991; 9(10-12):877-82. doi: 10.1016/0731-7085(91)80017-4. [PMID: 1822207]
  • P Hubert, P Chiap, J Crommen. Automatic determination of diltiazem and desacetyldiltiazem in human plasma using liquid-solid extraction on disposable cartridges coupled to HPLC--Part II: Optimization of liquid-solid extraction. Journal of pharmaceutical and biomedical analysis. 1991; 9(10-12):883-7. doi: 10.1016/0731-7085(91)80018-5. [PMID: 1822208]
  • S C Tsao, T H Dickinson, D R Abernethy. Metabolite inhibition of parent drug biotransformation. Studies of diltiazem. Drug metabolism and disposition: the biological fate of chemicals. 1990 Mar; 18(2):180-2. doi: . [PMID: 1971570]
  • P Du Souich, N Lery, L Lery, F Varin, S Boucher, M Vezina, D Pilon, J Spenard, G Caillé. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules. Biopharmaceutics & drug disposition. 1990 Mar; 11(2):137-47. doi: 10.1002/bdd.2510110206. [PMID: 2328299]
  • F F Ververs, H G Schaefer, J F Lefevre, L M Lopez, H Derendorf. Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography. Journal of pharmaceutical and biomedical analysis. 1990; 8(6):535-9. doi: 10.1016/0731-7085(90)80064-v. [PMID: 2093390]
  • S Kurosawa, N Kurosawa, E Owada, H Soeda, K Ito. Pharmacokinetics of diltiazem in patients with liver cirrhosis. International journal of clinical pharmacology research. 1990; 10(6):311-8. doi: NULL. [PMID: 2099357]
  • R A Boyd, S K Chin, O Don-Pedro, D Verotta, L B Sheiner, R L Williams, K M Giacomini. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clinical pharmacology and therapeutics. 1989 Oct; 46(4):408-19. doi: 10.1038/clpt.1989.159. [PMID: 2791444]
  • P Höglund, L G Nilsson. Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers. Therapeutic drug monitoring. 1989 Sep; 11(5):543-50. doi: NULL. [PMID: 2815229]
  • P Höglund, L G Nilsson. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers. Therapeutic drug monitoring. 1989 Sep; 11(5):558-66. doi: NULL. [PMID: 2815231]
  • P Höglund, L G Nilsson. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers. Therapeutic drug monitoring. 1989 Sep; 11(5):551-7. doi: NULL. [PMID: 2815230]
  • H Zhao, M S Chow. Analysis of diltiazem and desacetyldiltiazem in plasma using modified high-performance liquid chromatography: improved sensitivity and reproducibility. Pharmaceutical research. 1989 May; 6(5):428-30. doi: 10.1023/a:1015943801775. [PMID: 2748535]
  • N Shibata, K Morita, T Ono, S Nishikawa, M Kinoshita, S Kawakita, K Takada, S Muranishi, H Shimakawa. Effects of diltiazem on rheological properties of human blood. Journal of pharmacobio-dynamics. 1988 Mar; 11(3):175-80. doi: 10.1248/bpb1978.11.175. [PMID: 3411434]
  • P Höglund, L G Nilsson. Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers. Therapeutic drug monitoring. 1988; 10(4):401-9. doi: 10.1097/00007691-198804000-00006. [PMID: 3201524]
  • S C Montamat, D R Abernethy. N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives. British journal of clinical pharmacology. 1987 Aug; 24(2):185-9. doi: 10.1111/j.1365-2125.1987.tb03160.x. [PMID: 3620292]
  • S J Downing, D Edwards, M Hollingsworth. Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects. British journal of pharmacology. 1987 Aug; 91(4):735-45. doi: 10.1111/j.1476-5381.1987.tb11271.x. [PMID: 3664075]
  • O Grech-Belanger, E Leboeuf, S Langlois. Assay of diltiazem and deacetyldiltiazem by capillary gas chromatography. Journal of chromatography. 1987 Jun; 417(1):89-98. doi: 10.1016/0378-4347(87)80094-4. [PMID: 3624405]
  • S C Montamat, D R Abernethy, J R Mitchell. High-performance liquid chromatographic determination of diltiazem and its major metabolites, N-monodemethyldiltiazem and desacetyldiltiazem, in plasma. Journal of chromatography. 1987 Mar; 415(1):203-7. doi: 10.1016/s0378-4347(00)83211-9. [PMID: 3584358]
  • R K Bhamra, A E Ward, D W Holt. HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma. Biomedical chromatography : BMC. 1987; 2(4):180-2. doi: 10.1002/bmc.1130020412. [PMID: 3507233]
  • K A Ellenbogen, S F Roark, M S Smith, E A McCarthy, T D Bjornsson, E L Pritchett. Effects of sustained intravenous diltiazem infusion in healthy persons. The American journal of cardiology. 1986 Nov; 58(11):1055-60. doi: 10.1016/0002-9149(86)90114-1. [PMID: 3776858]
  • C D Kinney, J G Kelly. Estimation of concentrations of diltiazem in plasma using normal-phase column liquid chromatography with ultraviolet detection. Journal of chromatography. 1986 Oct; 382(?):377-81. doi: 10.1016/s0378-4347(00)83547-1. [PMID: 3782408]
  • D R Abernethy, J B Schwartz, E L Todd. Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivation. Journal of chromatography. 1985 Jul; 342(1):216-20. doi: 10.1016/s0378-4347(00)84507-7. [PMID: 4044752]
  • L C Winship, J M McKenney, J T Wright, J H Wood, R P Goodman. The effect of ranitidine and cimetidine on single-dose diltiazem pharmacokinetics. Pharmacotherapy. 1985 Jan; 5(1):16-9. doi: 10.1002/j.1875-9114.1985.tb04451.x. [PMID: 3982974]
  • R E Wiens, D J Runser, J P Lacz, D C Dimmitt. Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography. Journal of pharmaceutical sciences. 1984 May; 73(5):688-9. doi: 10.1002/jps.2600730525. [PMID: 6737244]
  • J P Clozel, G Caillé, Y Taeymans, P Théroux, P Biron, J G Besner. Improved gas chromatographic determination of diltiazem and deacetyldiltiazem in human plasma. Journal of pharmaceutical sciences. 1984 Feb; 73(2):207-9. doi: 10.1002/jps.2600730215. [PMID: 6707884]
  • M S Smith, C P Verghese, D G Shand, E L Pritchett. Pharmacokinetic and pharmacodynamic effects of diltiazem. The American journal of cardiology. 1983 May; 51(8):1369-74. doi: 10.1016/0002-9149(83)90314-4. [PMID: 6846164]